Not applicableEnded earlyNCT01187381
What this trial is testing
An Observational Study of the Mean Duration of Trastuzumab (Herceptin) Treatment in Participants With Early or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
Who this might be right for
Breast Cancer
Hoffmann-La Roche 250